Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor activity	FLT4 NRP2	2.24e-04	7	66	2	GO:0005021
GeneOntologyMolecularFunction	lipoteichoic acid binding	CD6 TLR2	2.24e-04	7	66	2	GO:0070891
Domain	UPF0560	FAM171A2 FAM171B	3.46e-05	3	64	2	PF10577
Domain	Uncharacterised_FAM171	FAM171A2 FAM171B	3.46e-05	3	64	2	IPR018890
Domain	ig	LILRA2 FLT4 KIR2DS2 KIR2DL2 KIR2DL3	4.85e-04	190	64	5	PF00047
Domain	Immunoglobulin	LILRA2 FLT4 KIR2DS2 KIR2DL2 KIR2DL3	4.85e-04	190	64	5	IPR013151
Domain	IG	LILRA2 FLT4 SLAMF9 KIR2DS2 KIR2DL2 KIR2DL3 LRIT3	5.78e-04	421	64	7	SM00409
Domain	Ig_sub	LILRA2 FLT4 SLAMF9 KIR2DS2 KIR2DL2 KIR2DL3 LRIT3	5.78e-04	421	64	7	IPR003599
Domain	IG_LIKE	LILRA2 FLT4 SLAMF9 KIR2DS2 KIR2DL2 KIR2DL3 LRIT3	1.42e-03	491	64	7	PS50835
Domain	Ig-like_dom	LILRA2 FLT4 SLAMF9 KIR2DS2 KIR2DL2 KIR2DL3 LRIT3	1.63e-03	503	64	7	IPR007110
Domain	-	LILRA2 FLT4 SLAMF9 PTPRO KIR2DS2 KIR2DL2 KIR2DL3 LRIT3	1.85e-03	663	64	8	2.60.40.10
Domain	Ig-like_fold	LILRA2 FLT4 SLAMF9 PTPRO KIR2DS2 KIR2DL2 KIR2DL3 LRIT3	2.74e-03	706	64	8	IPR013783
Pubmed	Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.	KIR2DS2 KIR2DL2 KIR2DL3	6.83e-09	3	67	3	30696053
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	6.83e-09	3	67	3	22960345
Pubmed	Imputation of KIR Types from SNP Variation Data.	KIR2DS2 KIR2DL2 KIR2DL3	6.83e-09	3	67	3	26430804
Pubmed	Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.	KIR2DS2 KIR2DL2 KIR2DL3	6.83e-09	3	67	3	18292496
Pubmed	Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.	KIR2DS2 KIR2DL2 KIR2DL3	2.73e-08	4	67	3	16929347
Pubmed	KIR/HLA ligand incompatibility in kidney transplantation.	KIR2DS2 KIR2DL2 KIR2DL3	2.73e-08	4	67	3	18091530
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	6.81e-08	5	67	3	16112031
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL2 KIR2DL3	6.81e-08	5	67	3	18755860
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	1.36e-07	6	67	3	17882223
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL2 KIR2DL3	2.38e-07	7	67	3	11169255
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DL2 KIR2DL3	3.80e-07	8	67	3	17200871
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL2 KIR2DL3	3.80e-07	8	67	3	18681957
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL2 KIR2DL3	5.69e-07	9	67	3	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3	5.69e-07	9	67	3	8662091
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL2 KIR2DL3	8.12e-07	10	67	3	12559621
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL2 KIR2DL3	1.12e-06	11	67	3	18830515
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL2 KIR2DL3	1.12e-06	11	67	3	19664392
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL2 KIR2DL3	1.48e-06	12	67	3	20371502
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL2 KIR2DL3	1.48e-06	12	67	3	19181658
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL2 KIR2DL3	1.48e-06	12	67	3	19936734
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	RAPH1 SYNE1 DUSP16 AMBRA1 KDM7A	1.64e-06	102	67	5	11214970
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL2 KIR2DL3	1.93e-06	13	67	3	18687225
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL2 KIR2DL3	1.93e-06	13	67	3	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL2 KIR2DL3	1.93e-06	13	67	3	19120281
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL2 KIR2DL3	2.45e-06	14	67	3	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL2 KIR2DL3	2.45e-06	14	67	3	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL2 KIR2DL3	2.45e-06	14	67	3	15896204
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL2 KIR2DL3	2.45e-06	14	67	3	19489269
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	20082646
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	19926642
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	19850842
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	19493232
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	20356536
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DL2 KIR2DL3	3.06e-06	15	67	3	19326408
Pubmed	Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	25359276
Pubmed	Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	26423800
Pubmed	MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion.	MUC16 NRP2	3.66e-06	2	67	2	35533267
Pubmed	KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	22836042
Pubmed	Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	33846289
Pubmed	Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.	VWF AVPR2	3.66e-06	2	67	2	10880054
Pubmed	Neuropilin-2 Is a Newly Identified Target of PAX8 in Thyroid Cells.	PAX8 NRP2	3.66e-06	2	67	2	26030152
Pubmed	Expression of KIR2DL3 and KIR2DS2 natural killer receptors in exercise.	KIR2DS2 KIR2DL3	3.66e-06	2	67	2	21165439
Pubmed	Identification of four novel KIR2DL2 alleles and two novel KIR2DL3 alleles in an East African population.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	20875478
Pubmed	KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	30689576
Pubmed	Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels.	VWF AVPR2	3.66e-06	2	67	2	20403097
Pubmed	Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	32961633
Pubmed	Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.	KIR2DS2 KIR2DL3	3.66e-06	2	67	2	18158964
Pubmed	The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	22024796
Pubmed	Killer cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft function.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	17445184
Pubmed	KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	27251940
Pubmed	Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	15248031
Pubmed	High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	24122895
Pubmed	Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	23686481
Pubmed	Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	26202659
Pubmed	Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	22715396
Pubmed	Association of killer cell immunoglobulin-like receptors with scleroderma.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	15146426
Pubmed	Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	25636579
Pubmed	KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles.	KIR2DL2 KIR2DL3	3.66e-06	2	67	2	27030405
Pubmed	[Correlation analysis between killer cell immunoglobulin-like receptor gene polymorphism and primary biliary cirrhosis].	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	25575065
Pubmed	The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.	KIR2DS2 KIR2DL3	3.66e-06	2	67	2	9497500
Pubmed	Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.	KIR2DS2 KIR2DL2	3.66e-06	2	67	2	35154153
Pubmed	Killer cell immunoglobulin receptor profile on CD4(+) CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.	KIR2DS2 KIR2DL3	3.66e-06	2	67	2	25484131
Pubmed	Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations.	FLT4 NRP2	3.66e-06	2	67	2	22961441
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	20670355
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	20652381
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	18668235
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	18643961
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	19309280
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	20331834
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	16403292
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DL2 KIR2DL3	3.76e-06	16	67	3	20210919
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	20483367
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	19968064
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	19169284
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	20650299
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DL2 KIR2DL3	4.56e-06	17	67	3	19761533
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS2 KIR2DL2 KIR2DL3	5.46e-06	18	67	3	19630074
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS2 KIR2DL2 KIR2DL3	5.46e-06	18	67	3	20519398
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DL2 KIR2DL3	5.46e-06	18	67	3	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DL2 KIR2DL3	5.46e-06	18	67	3	19046302
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DL2 KIR2DL3	5.46e-06	18	67	3	19846535
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DL2 KIR2DL3	5.46e-06	18	67	3	20580654
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DS2 KIR2DL2 KIR2DL3	5.46e-06	18	67	3	20210918
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS2 KIR2DL2 KIR2DL3	6.48e-06	19	67	3	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS2 KIR2DL2 KIR2DL3	6.48e-06	19	67	3	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS2 KIR2DL2 KIR2DL3	6.48e-06	19	67	3	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS2 KIR2DL2 KIR2DL3	6.48e-06	19	67	3	18848853
Cytoband	19q13.4	LILRA2 KIR2DS2 KIR2DL2 KIR2DL3	5.73e-06	79	67	4	19q13.4
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL2 KIR2DL3	1.48e-05	18	49	3	620
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	LILRA2 CD6 TLR2 KIR2DS2 KIR2DL2 KIR2DL3	6.53e-04	394	49	6	471
GeneFamily	CD molecules\|Mucins	OVGP1 MUC16	1.46e-03	21	49	2	648
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C AVPR2 MYCT1 NRP2	3.52e-07	190	65	6	32400c62cb9de4c2b24af4206c21a0215ab12212
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 VWF MYCT1 SYNE1 PEAK1 NRG3	3.98e-07	194	65	6	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF AVPR2 MYCT1 FAM171B NRP2	4.10e-07	195	65	6	590c0dc0db4dc62879645ed7f61292ff97d2c7d5
ToppCell	10x5'-Liver-Lymphocytic_T_CD4\|Liver / Manually curated celltypes from each tissue	RAPGEF6 CD6 MAST4 DUSP16 IDS ZC3HAV1	4.35e-07	197	65	6	4891111894b741555f549deec6af8006376d9358
ToppCell	Endothelial-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	FLT4 VWF AVPR2 MYCT1 FAM171B	4.85e-06	169	65	5	8889c9e8af1ab0b093d57b69abd80b59b3461be9
ToppCell	metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	FLT4 VWF PLA2G4C AVPR2 MYCT1	5.59e-06	174	65	5	d551bc29afef071adf4c9bb80345352ec33441d8
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BLM TICRR SLAMF9 TLR2 CRAMP1	6.08e-06	177	65	5	1d5a071157c755f3a27a5c3143015da04ee0b0dc
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	6.42e-06	179	65	5	1c0c0647a111f691dae55f4ed8c51006059ce020
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAP1GAP MAST4 SLC12A1 VWA8 CADPS2	6.59e-06	180	65	5	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	FLT4 PLA2G4C SYNE1 NRG3 CADPS2	6.77e-06	181	65	5	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF MYCT1 SYNE1 NRP2	6.96e-06	182	65	5	fd786c88826ad3d5cc5c3d80f8e392d6be1b5267
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	FLT4 VWF AVPR2 MYCT1 NRG3	6.96e-06	182	65	5	d7cce5dd7046f06bf40f00c9dbfa610722b03333
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RAPH1 DUSP16 TLR2 KDM7A NRP2	6.96e-06	182	65	5	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	7.14e-06	183	65	5	764ea07621f77fbd13a877aed5806ae2b3dfb43e
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	7.14e-06	183	65	5	38a54216458ad57f356bb4ddf272e1af8036ddeb
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	RAP1GAP MAST4 SYNE1 STEAP4 CADPS2	7.14e-06	183	65	5	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STIM2 SLC12A1 TLR2 FAM171B NRG3	7.33e-06	184	65	5	8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF MYCT1 SYNE1 NRP2	7.33e-06	184	65	5	453295362888c9a59d0e73c7a5b15914c50ff591
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLT4 PLA2G4C MYCT1 NRG3 NRP2	7.53e-06	185	65	5	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	7.53e-06	185	65	5	fb84fcf7f51f53489bcb3962fa9cb483e48257ed
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A2 MYCT1 PEAK1 NRP2 SLC66A3	7.73e-06	186	65	5	37860daeecd6d412bd3797f30496a56da667fbd1
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	7.73e-06	186	65	5	9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A2 MYCT1 PEAK1 NRP2 SLC66A3	7.73e-06	186	65	5	60830822d3de3147816693404fd03392e04c2b8e
ToppCell	droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM171A2 MYCT1 PEAK1 NRP2 SLC66A3	7.73e-06	186	65	5	baebeffdd426ce767190ddefc857cc78e6a58d36
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	FLT4 VWF AVPR2 MYCT1 NRG3	7.93e-06	187	65	5	be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLT4 PLA2G4C SYNE1 NRG3 CADPS2	8.35e-06	189	65	5	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF MYCT1 SYNE1 PEAK1 CADPS2	8.35e-06	189	65	5	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	8.57e-06	190	65	5	b2bd2cb384bb8a5662064ed1aee68e905e1f780d
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	STIM2 VWF NRG3 CADPS2 NRP2	8.57e-06	190	65	5	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF MYCT1 SYNE1 NRG3 CADPS2	8.79e-06	191	65	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FLT4 VWF AVPR2 MYCT1 NRG3	9.01e-06	192	65	5	7dbe3117a0f58ff2e838963d49f788a59a4351d7
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	9.01e-06	192	65	5	fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	9.01e-06	192	65	5	4e63d95f75fe6eb3f817e84528883e95093c5bbd
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	VWF MYCT1 SYNE1 NRG3 CADPS2	9.01e-06	192	65	5	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RAP1GAP MAST4 TLR2 STEAP4 CADPS2	9.01e-06	192	65	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	VWF MYCT1 SYNE1 NRG3 CADPS2	9.24e-06	193	65	5	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 NRP2	9.24e-06	193	65	5	ef007b736da56529ec628fc3df86a335e7ec3f18
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 VWF MYCT1 PEAK1 NRG3	9.48e-06	194	65	5	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STIM2 RAPH1 AVPR2 CADPS2 ZC3HAV1	9.48e-06	194	65	5	d602a0cdb69cd5a3e9ef61ddbab8d920557dd73e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 VWF MYCT1 PEAK1 NRG3	9.48e-06	194	65	5	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	FLT4 VWF MYCT1 SYNE1 CADPS2	9.72e-06	195	65	5	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	Monocytes-NUPR1+_Monocytes\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	LILRA2 PTPRO PAX8 TLR2 NRP2	9.72e-06	195	65	5	5e12201ce7ba912e7faa123ca200e609252ba288
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT4 VWF PLA2G4C MYCT1 NRG3	9.72e-06	195	65	5	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	3'-Adult-LymphNode-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 FAM171B	9.96e-06	196	65	5	a2845436003e9adf34677eb81e78f8334ff01faa
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLT4 VWF PLA2G4C MYCT1 NRP2	9.96e-06	196	65	5	09a7edf4a7defb7fe70d9777dd9500ee8421ff31
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLT4 VWF PLA2G4C MYCT1 NRP2	9.96e-06	196	65	5	e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 PLA2G4C SYNE1 NRG3 CADPS2	9.96e-06	196	65	5	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1 FAM171B	9.96e-06	196	65	5	aa52f77f80c3fe23369347a34e0b3188b768a763
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	FLT4 PLA2G4C SYNE1 NRG3 CADPS2	9.96e-06	196	65	5	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FLT4 VWF AVPR2 MYCT1 NRG3	1.02e-05	197	65	5	21a1080e1db3a64f3eccc7aed2b3189332d31038
ToppCell	3'-Child09-12-SmallIntestine-Endothelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF AVPR2 MYCT1 NRP2	1.02e-05	197	65	5	86a02fd7b4762b3278e5e60b5483b5fc1206e597
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	FLT4 VWF MYCT1 SYNE1 CADPS2	1.02e-05	197	65	5	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	10x3'2.3-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FLT4 VWF MAST4 MYCT1 NRP2	1.05e-05	198	65	5	2630a7a6e56febe5c0b0bde70dd7292fa1650c47
ToppCell	5'-Adult-LymphNode-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF AVPR2 MYCT1 FAM171B	1.05e-05	198	65	5	d7e15e61b6018e4c36461c9471ee29601929925c
ToppCell	ASK428-Endothelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	FLT4 VWF MYCT1 FAM171B NRP2	1.05e-05	198	65	5	d69d0ff115298596173a4278897a65007a71f5df
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FLT4 VWF MAST4 MYCT1 NRP2	1.05e-05	198	65	5	1e83bec16dcd60460422625f89952ff506d6be51
ToppCell	Skin-Endothelial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	FLT4 VWF AVPR2 MYCT1 CADPS2	1.07e-05	199	65	5	6b3ef5d8f87cdfe5401d05f19339ddfcd9cda476
ToppCell	LA-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLT4 VWF NRG3 LRIT3	3.70e-05	128	65	4	071becbe97598c2b65580b0989eb664d6fd6c85a
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CRISP2 PTPRO CADPS2 SORCS1	3.93e-05	130	65	4	56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STIM2 PAX8 AVPR2 CADPS2	8.81e-05	160	65	4	7064af50fc10e3ea03badf415306222b74db0f95
ToppCell	NS-critical-d_16-33-Myeloid-Mast_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FLT4 PAX8 IDS SORCS1	8.81e-05	160	65	4	c61869d9dbba250270e59366e15af204e5b4395d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD6 SYNE1 KIR2DL3 FAM171B	9.24e-05	162	65	4	3b89c3758835b7b9f9d4fb0bc8ed06da382fe48b
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FLT4 MYCT1 TLR2 NRP2	9.46e-05	163	65	4	c21114826bee1b05b411984326fef6b6e0d05316
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FLT4 MYCT1 TLR2 NRP2	9.46e-05	163	65	4	5d49414432db259a19df50d7944581d00b69f537
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DAGLB FAM171B ZNF692 CRAMP1	9.92e-05	165	65	4	66f0364098d82629aa2ec1dfe0c5ad23de7c2c12
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1	1.02e-04	166	65	4	941d6aa94ab9d36e5f6c40f446c926754e070d56
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C MYCT1	1.02e-04	166	65	4	6f5ecf3b2cf613ae0535ab3d21d93622f1497571
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	FLT4 VWF PLA2G4C NRG3	1.04e-04	167	65	4	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	Endothelial-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	FLT4 MYCT1 FAM171B NRG3	1.09e-04	169	65	4	95c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 MYCT1 SYNE1 NRG3	1.09e-04	169	65	4	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF MYCT1 NRP2	1.11e-04	170	65	4	4848965bc7e9356c6601bb41eeea1553d2eea87e
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT4 PRRX2 NRP2 SORCS1	1.14e-04	171	65	4	686f95892c3909973c66c9a27159a070a068f175
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT4 PRRX2 NRP2 SORCS1	1.14e-04	171	65	4	f7ba03e7bdb687f93782c936c7b3374cc5b3b77c
ToppCell	PND14-Endothelial-Endothelial_lymphatic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT4 PRRX2 NRP2 SORCS1	1.14e-04	171	65	4	d0ac50071a3854d02113c455fcc940a6ec59bbb9
ToppCell	PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT4 PRRX2 NRP2 SORCS1	1.14e-04	171	65	4	fbf8e9db00573adcada4b25730e191417b7c9999
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RAPGEF6 SYNE1 DUSP16 ZC3HAV1	1.14e-04	171	65	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 MAST4 MYCT1 NRP2	1.16e-04	172	65	4	a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF PLA2G4C NRP2	1.16e-04	172	65	4	1bad7b19724e1b53ace7e05644215334c9f43910
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAGLB BLM DUSP16 IDS	1.19e-04	173	65	4	c31076c725f4cd912c56903592a2d9356ae59f54
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 MYCT1 CRAMP1 NRP2	1.19e-04	173	65	4	85083b9ce20351dd69aa2327ad087b848b4307ff
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAGLB BLM DUSP16 IDS	1.19e-04	173	65	4	a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 MAST4 MYCT1 NRP2	1.27e-04	176	65	4	3494ffa8555e6edf4b1250e10434bae9b73ec845
ToppCell	ASK452-Endothelial-Lymphatic\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	FLT4 RAPH1 MYCT1 FAM171B	1.27e-04	176	65	4	b4d280ecc07701d526f50d44c45ea91b3eeb00b1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT4 PLA2G4C SYNE1 NRG3	1.27e-04	176	65	4	dc5a22f9d1347f157bdd93e6e5769b983deccf1a
ToppCell	droplet-Liver-Npc-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT4 MAST4 MYCT1 NRP2	1.27e-04	176	65	4	d43f6b7828b98e1dab7b726a5f99499d65a7db80
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.30e-04	177	65	4	76f5df101c693e5fa61554244d877fc8169ee66f
ToppCell	metastatic_Lymph_Node-Endothelial_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	FLT4 VWF AVPR2 MYCT1	1.30e-04	177	65	4	71bf5d4bc67bda37a0499e5ec01af7dd5254041d
ToppCell	3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 AVPR2 MYCT1 NRP2	1.30e-04	177	65	4	dfaed388926ce050730492a532824af68bf4feff
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.30e-04	177	65	4	d6596a0b6fd146fefc27717c1a7dbaa3774cc644
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.33e-04	178	65	4	4ef6344d0ffc9c55b1240bee94b741382f1427bb
ToppCell	3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.33e-04	178	65	4	c65932cbedbbfacb6f0299280663fe7c88dba72b
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FLT4 MYCT1 PEAK1 NRP2	1.33e-04	178	65	4	ad3de3e03a401dac64431a541899445262246347
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.36e-04	179	65	4	abc6797bd3884aa75dca58fcb2523ee321243ab1
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.36e-04	179	65	4	0b996d6e881f31e6b80d359f7caac70ecdeb9982
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FLT4 PLA2G4C MYCT1 NRG3	1.36e-04	179	65	4	ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.36e-04	179	65	4	dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FLT4 PLA2G4C MYCT1 NRG3	1.36e-04	179	65	4	35fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCell	COVID-19-Heart-Lymph_EC\|Heart / Disease (COVID-19 only), tissue and cell type	CRISP2 FLT4 NRG3 NRP2	1.36e-04	179	65	4	411620201a860716a8773b92f50f7b94ef34a586
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 VWF AVPR2 MYCT1	1.39e-04	180	65	4	755050226eeb1991ee7f0d15e39d0458f3e4a791
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT4 PLA2G4C MYCT1 NRP2	1.39e-04	180	65	4	25f8e82bbc1853cb7d072484e99369c72779dd1e
Drug	Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; HL60; HT_HG-U133A	LILRA2 CD6 PAX8 KLHL36 IDS SLC48A1 ALDH6A1 NRP2	1.10e-07	199	66	8	3011_DN
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A	CRISP2 OVGP1 PAX8 IDS SLC48A1 ALDH6A1 PRRX2	1.83e-06	200	66	7	3056_UP
Drug	Aa1	CRISP2 SYNE1 MARCHF7 KIR2DL2 KIR2DL3	4.28e-06	83	66	5	CID009549188
Drug	Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A	FLT4 MAST4 PLA2G4C TLR2 SLC48A1 ABCA7	1.82e-05	189	66	6	7206_UP
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	SYNE1 TLR2 ZMYM2 AMBRA1 IDS ALDH6A1	1.93e-05	191	66	6	7376_DN
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; HL60; HT_HG-U133A	LILRA2 RAP1GAP KLHL36 PAFAH1B1 SLC48A1 ZFPL1	2.23e-05	196	66	6	2551_DN
Drug	Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; HL60; HT_HG-U133A	CRISP2 FLT4 CD6 PAX8 STEAP4 ALDH6A1	2.23e-05	196	66	6	2741_UP
Drug	Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A	FANCF SETD1B TLR2 CADPS2 ALDH6A1 ABCA7	2.29e-05	197	66	6	2091_UP
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A	CD6 PLA2G4C TLR2 ZMYM2 SLC48A1 ZFPL1	2.29e-05	197	66	6	1707_UP
Drug	Streptozotocin [18883-66-4]; Down 200; 15uM; HL60; HT_HG-U133A	LILRA2 FLT4 CD6 STEAP4 SLC48A1 ABCA7	2.36e-05	198	66	6	2535_DN
Drug	1,7-octadiene	VWF SYNE1	4.95e-05	4	66	2	CID000019460
Drug	2-Cl	SLC12A1 SYNE1 IDS	1.42e-04	35	66	3	CID000081058
Drug	Disulfiram [97-77-8]; Up 200; 13.4uM; PC3; HT_HG-U133A	VWA8 ZMYM2 KDM7A IDS ZFPL1	1.91e-04	183	66	5	2053_UP
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A	OVGP1 PAX8 IDS SLC48A1 NRP2	2.11e-04	187	66	5	3037_UP
Drug	DIBAH	SLC12A1 SYNE1	2.29e-04	8	66	2	CID000014487
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	OVGP1 SETD1B MAST4 ABCA7 ZFPL1	2.38e-04	192	66	5	6958_UP
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	CD6 SYNE1 ZMYM2 SLC48A1 ALDH6A1	2.44e-04	193	66	5	2093_UP
Drug	Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A	FLT4 OVGP1 CD6 PAFAH1B1 STEAP4	2.50e-04	194	66	5	6763_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	ZSWIM8 PTPRO PAX8 ABCA7 NRP2	2.56e-04	195	66	5	6063_UP
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	OVGP1 KLHL36 TLR2 STEAP4 SLC48A1	2.56e-04	195	66	5	5103_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; HL60; HT_HG-U133A	CD6 PAX8 STEAP4 IDS ALDH6A1	2.56e-04	195	66	5	2544_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A	CRISP2 CD6 SLC48A1 ABCA7 NRP2	2.56e-04	195	66	5	4467_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	BLM OVGP1 MAST4 ABCA7 ZFPL1	2.56e-04	195	66	5	5579_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A	KLHL36 PAFAH1B1 ZMYM2 IDS ALDH6A1	2.62e-04	196	66	5	5360_DN
Drug	radicicol; Up 200; 0.1uM; SKMEL5; HG-U133A	FANCF LILRA2 PAX8 LAS1L ZC3HAV1	2.62e-04	196	66	5	493_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	FANCF LILRA2 AMBRA1 ZFPL1 ZC3HAV1	2.62e-04	196	66	5	1164_DN
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; PC3; HT_HG-U133A	ZSWIM8 MAST4 STEAP4 KDM7A CADPS2	2.62e-04	196	66	5	7371_UP
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	FLT4 OVGP1 PAX8 IDS ZNF692	2.62e-04	196	66	5	832_UP
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; PC3; HT_HG-U133A	RAP1GAP KLHL36 AMBRA1 ALDH6A1 ZC3HAV1	2.62e-04	196	66	5	7278_DN
Drug	Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A	KLHL36 ZMYM2 SLC48A1 ALDH6A1 ZNF692	2.62e-04	196	66	5	4769_DN
Drug	Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; HL60; HT_HG-U133A	LILRA2 FLT4 PAX8 PAFAH1B1 KDM7A	2.62e-04	196	66	5	2521_DN
Drug	0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A	OVGP1 VWA8 SYNE1 ZMYM2 ZC3HAV1	2.62e-04	196	66	5	7057_DN
Drug	dexamethasone; Down 200; 1uM; MCF7; HG-U133A	LILRA2 PAX8 AMBRA1 SLC48A1 NRP2	2.69e-04	197	66	5	255_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; HL60; HG-U133A	FANCF ZSWIM8 KLHL36 ZMYM2 IDS	2.69e-04	197	66	5	1576_UP
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A	LILRA2 OVGP1 SETD1B PAFAH1B1 AMBRA1	2.69e-04	197	66	5	1368_DN
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A	OVGP1 VWA8 KLHL36 AMBRA1 SLC48A1	2.69e-04	197	66	5	2059_UP
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	OVGP1 PAX8 STEAP4 ABCA7 ZFPL1	2.69e-04	197	66	5	1528_UP
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	RAP1GAP KLHL36 SLC48A1 ALDH6A1 ZC3HAV1	2.69e-04	197	66	5	7276_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; PC3; HT_HG-U133A	CRISP2 PAX8 STEAP4 SLC48A1 ALDH6A1	2.69e-04	197	66	5	4684_DN
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	OVGP1 STEAP4 IDS ZNF692 ZC3HAV1	2.69e-04	197	66	5	2695_DN
Drug	Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A	CD6 STEAP4 SLC48A1 NRP2 SLC66A3	2.69e-04	197	66	5	3201_UP
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; PC3; HT_HG-U133A	FLT4 MAST4 VWA8 IDS SLC48A1	2.69e-04	197	66	5	7153_UP
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	FLT4 MAST4 PLA2G4C ABCA7 ZFPL1	2.69e-04	197	66	5	3937_DN
Drug	PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A	CD6 SETD1B KLHL36 ZMYM2 NRP2	2.69e-04	197	66	5	6563_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAST4 PLA2G4C SYNE1 STEAP4 ZFPL1	2.69e-04	197	66	5	4764_DN
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	OVGP1 CD6 PAX8 AMBRA1 ALDH6A1	2.69e-04	197	66	5	7283_UP
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PLA2G4C PAX8 SLC48A1 ALDH6A1 ABCA7	2.75e-04	198	66	5	6025_UP
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; PC3; HT_HG-U133A	CRISP2 ZMYM2 STEAP4 KDM7A IDS	2.75e-04	198	66	5	4636_DN
Drug	Cefoperazone dihydrate; Up 200; 5.8uM; PC3; HT_HG-U133A	KLHL36 ZMYM2 ALDH6A1 ABCA7 NRP2	2.75e-04	198	66	5	6323_UP
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	LILRA2 RAP1GAP CD6 PEAK1 IDS	2.75e-04	198	66	5	2411_DN
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A	SYNE1 AMBRA1 SLC48A1 ABCA7 NRP2	2.75e-04	198	66	5	7317_UP
Drug	Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	OVGP1 MAST4 KDM7A SLC48A1 NRP2	2.75e-04	198	66	5	7233_UP
Drug	alpha-Santonin [481-06-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	CD6 PTPRO PAX8 MYCT1 SLC66A3	2.75e-04	198	66	5	4353_UP
Drug	Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A	PAX8 SYNE1 ALDH6A1 NRP2 SLC66A3	2.75e-04	198	66	5	3898_UP
Drug	Propidium iodide [25535-16-4]; Down 200; 6uM; HL60; HT_HG-U133A	LILRA2 FLT4 STEAP4 IDS ABCA7	2.75e-04	198	66	5	2541_DN
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CD6 PLA2G4C TLR2 STEAP4 ABCA7	2.81e-04	199	66	5	3198_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; HL60; HT_HG-U133A	FLT4 CD6 PAX8 KLHL36 SYNE1	2.81e-04	199	66	5	2198_UP
Drug	Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	FLT4 PAX8 IDS ZFPL1 NRP2	2.81e-04	199	66	5	6687_UP
Drug	Rifampicin [13292-46-1]; Down 200; 4.8uM; PC3; HT_HG-U133A	FLT4 PAX8 STEAP4 IDS SLC48A1	2.81e-04	199	66	5	4008_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; HL60; HG-U133A	FANCF LILRA2 SETD1B ZMYM2 AMBRA1	2.81e-04	199	66	5	1439_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; PC3; HT_HG-U133A	FLT4 OVGP1 SYNE1 AMBRA1 ALDH6A1	2.81e-04	199	66	5	7281_UP
Drug	Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; PC3; HT_HG-U133A	FLT4 PAX8 STEAP4 SLC48A1 NRP2	2.81e-04	199	66	5	3994_DN
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A	CD6 KLHL36 PAFAH1B1 AMBRA1 IDS	2.81e-04	199	66	5	5478_DN
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	ZSWIM8 PLA2G4C PEAK1 SLC48A1 SLC66A3	2.81e-04	199	66	5	5927_UP
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	ZSWIM8 STEAP4 SLC48A1 ALDH6A1 NRP2	2.81e-04	199	66	5	3164_UP
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	ZMYM2 STEAP4 IDS ALDH6A1 ABCA7	2.81e-04	199	66	5	4670_DN
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HT_HG-U133A	OVGP1 MAST4 TLR2 AMBRA1 ABCA7	2.81e-04	199	66	5	6655_DN
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; PC3; HT_HG-U133A	OVGP1 SYNE1 AMBRA1 SLC48A1 ALDH6A1	2.81e-04	199	66	5	5784_DN
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A	PAX8 AMBRA1 IDS SLC48A1 NRP2	2.88e-04	200	66	5	3008_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	CRISP2 FLT4 MAST4 PAX8 ABCA7	2.88e-04	200	66	5	6970_UP
Drug	Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; HL60; HT_HG-U133A	LILRA2 CD6 PAX8 KLHL36 SLC48A1	2.88e-04	200	66	5	2988_DN
Drug	Beta-sistosterol [83-46-5]; Up 200; 9.6uM; HL60; HT_HG-U133A	ZSWIM8 OVGP1 IDS ABCA7 NRP2	2.88e-04	200	66	5	2912_UP
Drug	Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CRISP2 ZSWIM8 CD6 AVPR2 SLC48A1	2.88e-04	200	66	5	7030_UP
Disease	keratoconjunctivitis (is_marker_for)	TLR2 MUC16	1.39e-05	3	64	2	DOID:9368 (is_marker_for)
Disease	Miller Dieker syndrome	BLM FANCF PAFAH1B1	3.42e-05	29	64	3	C0265219
Disease	internal carotid intimal medial thickness	MAST4 NRG3	4.61e-05	5	64	2	EFO_0005053
Disease	focal segmental glomerulosclerosis (is_marker_for)	RAP1GAP VWF	1.29e-04	8	64	2	DOID:1312 (is_marker_for)
Disease	dry eye syndrome (is_marker_for)	TLR2 MUC16	2.06e-04	10	64	2	DOID:10140 (is_marker_for)
Disease	pyroglutamine measurement	VWF SLC12A1 SORCS1	2.76e-04	58	64	3	EFO_0005408
Disease	MYELODYSPLASTIC SYNDROME	BLM FANCF TLR2	4.22e-04	67	64	3	C3463824
Disease	Schizophrenia	RAPGEF6 PLA2G4C PAFAH1B1 TLR2 AMBRA1 STH NRG3 CADPS2	6.27e-04	883	64	8	C0036341
Disease	bipolar disorder (is_marker_for)	RAP1GAP VWF	7.73e-04	19	64	2	DOID:3312 (is_marker_for)
Disease	Nystagmus	MAST4 IDS	9.47e-04	21	64	2	HP_0000639
Disease	Acute monocytic leukemia	BLM FANCF	1.46e-03	26	64	2	C0023465
Disease	Myocardial Failure	VWF AVPR2 TLR2	1.78e-03	110	64	3	C1959583
Disease	Congestive heart failure	VWF AVPR2 TLR2	1.78e-03	110	64	3	C0018802
Disease	Heart failure	VWF AVPR2 TLR2	1.78e-03	110	64	3	C0018801
Disease	Left-Sided Heart Failure	VWF AVPR2 TLR2	1.78e-03	110	64	3	C0023212
Disease	Heart Failure, Right-Sided	VWF AVPR2 TLR2	1.78e-03	110	64	3	C0235527
Disease	Heart Decompensation	VWF AVPR2 TLR2	1.78e-03	110	64	3	C1961112
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	PTPRO NUP133	1.94e-03	30	64	2	C1868672

Protein segments in the cluster

Peptide	Gene	Start	Entry
RTTPNYSSGEASSSW	AMBRA1	586	Q9C0C7
ENLYMSSDPTSWSSA	CRISP2	96	P16562
SSTVGPSLNWYEASD	ABCA7	231	Q8IZY2
ESAYDWTSLSSSSIK	RAPH1	521	Q70E73
SSYSEAWRFPNSSLL	PAX8	411	Q06710
CISWAPESSYSSISE	PAFAH1B1	281	P43034
SFRDSPYEWSNSSDP	KIR2DS2	201	P43631
SPDYLSWTASSPYST	PRRX2	196	Q99811
YSAHNLSSEWSAPSD	LILRA2	296	Q8N149
PADDSSSTSSGEWYQ	CD6	616	P30203
TSSYLHDSTPSWTLS	NRG3	231	P56975
VKSSPTWYSASSFSS	ALDH6A1	21	Q02252
TWYSASSFSSSVPTV	ALDH6A1	26	Q02252
STFLFDSLSTLDWDT	MUC16	3726	Q8WXI7
WSADLVALSYSSPSG	NUP133	151	Q8WUM0
SFRDSPYEWSNSSDP	KIR2DL2	201	P43627
LSSVETYSPKTDSWS	KLHL36	411	Q8N4N3
PTDENLARYESWSSS	KDM7A	306	Q6ZMT4
AVSSTTYVSTWDPAT	FANCF	16	Q9NPI8
SFRDSPYEWSNSSDP	KIR2DL3	201	P43628
IPQQWDESSSSSYAS	EZHIP	421	Q86X51
DPNWDASSAGSSISY	PEAK1	1191	Q9H792
SASSTQEYLWSPSAA	NRP2	451	O60462
TLDSLYWSVKPASSS	LAS1L	531	Q9Y4W2
SASSYLWSSSFSPTS	LRIT3	381	Q3SXY7
QSLTDPTSYYLSSVW	SLC48A1	101	Q6P1K1
SGWPDFNSSDYETTS	PTPRO	281	Q16827
SSTYSQLWASLTPAS	FAM171A2	166	A8MVW0
VSGSTWAISSLYTND	PLA2G4C	81	Q9UP65
TPYDWESLAKSSLSS	ERVK-5	346	Q9HDB9
SSPDLLTYFCWASST	C17orf99	91	Q6UX52
FSSSPDSLSTINDWD	BLM	141	P54132
LTRWSPAYSFSSDSP	DAGLB	566	Q8NCG7
PQTSTPSLTSSWYFA	DUSP16	546	Q9BY84
PSLTSSWYFATESSH	DUSP16	551	Q9BY84
QWYPSDSTDSSLSSL	CRAMP1	1151	Q96RY5
STASWMPSLYESTNG	CADPS2	991	Q86UW7
SASASPFQSAWYSES	MARCHF7	56	Q9H992
TTLPSTETLSWSSEY	MAST4	936	O15021
ISSNHTDDSPYSWSF	IDS	141	P22304
QQSLSGYSTLTWSSP	SEC24B	251	O95487
QSLPSQASDWSRYSS	FAM171B	611	Q6P995
EFSSTSLPQFWLSSA	OVGP1	386	Q12889
SAYTANTSASPTAAW	SLC18A3	91	Q16572
KSWTSSSSLSDTYEP	RAPGEF6	1431	Q8TEU7
SLEESESSLSSYSDW	SYNE1	3706	Q8NF91
ISTSHSLSRPDYWSS	MYCT1	196	Q8N699
SFIYSTWLEDSVSTT	RAP1GAP	606	P47736
WGSSTQALSYVSALD	SLC12A1	651	Q13621
DTLWVYHPSTSLSSA	SETD1B	1716	Q9UPS6
YDSSDNPYTRWLAST	NKX2-2	66	O95096
SAWHSTDSASPQTYE	TICRR	1546	Q7Z2Z1
TSDPYDFANSWALSS	VWF	181	P04275
LPSLTSSLYSDHSWV	STIM2	451	Q9P246
EASTGTYTLALWNSA	FLT4	391	P35916
PFSTSSAWLSDSYVA	STEAP4	336	Q687X5
GTIWPSSYSSEESSR	STH	71	Q8IWL8
PSYSLHISNLSWEDS	SLAMF9	91	Q96A28
YSSSSPIWSVDSDEP	UBE2Q2L	81	H0YL09
DSGTVSALTWSLSSY	SLC66A3	141	Q8N755
DSPVWYTSTSLDRNT	ZMYM2	1336	Q9UBW7
TAGPSASDQSTWYLD	ZSWIM8	276	A7E2V4
ASDQSTWYLDESTLT	ZSWIM8	281	A7E2V4
STYLASNSTSAPNWK	ZC3HAV1	346	Q7Z2W4
PDSSLHWSSSYSPET	ZNF396	36	Q96N95
SITESSLWRSTDYGT	SORCS1	201	Q8WY21
SESLSPYTTWLSTIS	VWA8	1471	A3KMH1
YLSNLSSSWFKPLSS	TLR2	111	O60603
SDFSDWSSFNASSTP	ZFPL1	151	O95159
NPWIYASFSSSVSSE	AVPR2	321	P30518
LSDASLWTYSSSPDD	ZNF692	206	Q9BU19